Digitisation | December 31, 2023
Adani and Sirius form JV to digitally transform India's digital economy
Sirius JV will be owned 51% by Sirius and 49% by Adani
Sirius JV will be owned 51% by Sirius and 49% by Adani
Furthering cell therapy ambition across oncology and autoimmune diseases
The plant is yet to start commercial operations
Receives registration of Valganciclovir powder for oral solution in Germany
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
New facility is part of Aptar Pharma’s global expansion program
The company is assessing the situation and simultaneously undertaking all the requisite action
The company has received Form 483 with three observations
Subscribe To Our Newsletter & Stay Updated
